US startup unveils real-time tool that makes blood translucent

US startup Ocutrx Technologies has unveiled HemoLucence, a pioneering surgical imaging technology that renders blood translucent in real time, allowing surgeons to see through pooled blood without suction or irrigation. Integrated into the OR Bot 3D Surgical Microscope, HemoLucence uses AI-powered algorithms and advanced computational physics to visualize tissue and structures obscured by blood, successfully penetrating up to three millimeters of whole human blood in lab tests. The system collects and analyzes light from multiple angles, separating scattered light from absorbed light to reconstruct a clear 3D view of hidden anatomy, including vessels, nerves, bleed sites, and tumors. This breakthrough addresses a longstanding challenge in operating room imaging by enabling surgeons to see through blood during procedures, potentially enhancing surgical precision and safety. Medical advisors from leading hospitals have praised the technology for its potential to reduce reliance on traditional blood-clearing methods, shorten surgery times, and improve outcomes. However, HemoLucence remains a prototype awaiting patent approval and must undergo clinical trials